Medicare Enrolled
Dr. Lowell Hart, M.D.
Medical Oncology · Fort Myers, FL
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Hart from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Hart? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Hart
Dr. Lowell Hart is a medical oncology in Fort Myers, FL, with 20 years in practice. Based on federal Medicare data, Dr. Hart performed 73,615 Medicare services across 3,005 unique beneficiaries.
Between the years covered by Open Payments, Dr. Hart received a total of $339,421 from 102 pharmaceutical and/or device companies across 1581 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in medical oncology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Hart is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice▲ Top 30% volume in FL$ $339,421 industry payments
Medicare Practice Summary
Medicare Utilization ↗73,615
Medicare services
Top 30% in FL for medical oncology
3,005
Unique beneficiaries
$13
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~3,681 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Feraheme) | 16,320 | $0 | $4 |
| Filgrastim injection (Zarxio) for white blood cells | 13,200 | $0 | $2 |
| Pembrolizumab injection (Keytruda) | 13,000 | $43 | $137 |
| Anti-nausea injection (aprepitant) | 7,670 | $1 | $5 |
| Denosumab injection (Prolia/Xgeva) | 5,940 | $18 | $51 |
| Epoetin alfa injection (Procrit) for anemia | 4,260 | $6 | $23 |
| Iron sucrose injection (Venofer) | 3,500 | $0 | $5 |
| Dexamethasone injection (steroid) | 1,530 | $0 | $3 |
| Complete blood count (CBC) with differential | 1,524 | $8 | $29 |
| Blood draw (venipuncture) | 1,332 | $8 | $9 |
| Anti-nausea injection (Aloxi/palonosetron) | 890 | $1 | $28 |
| Office visit, established patient (20-29 min) | 724 | $65 | $229 |
| Office visit, established patient (30-39 min) | 642 | $96 | $336 |
| Drug injection, under skin or into muscle | 417 | $11 | $69 |
| Anti-nausea injection (ondansetron/Zofran) | 416 | $0 | $9 |
| Injection of additional new drug or substance into vein | 377 | $12 | $61 |
| Administration of chemotherapy into vein, 1 hour or less | 287 | $103 | $378 |
| Infusion into a vein for hydration, each additional hour | 151 | $10 | $42 |
| Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | 150 | $1 | $6 |
| Infusion, normal saline solution , 1000 cc | 138 | $2 | $7 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 119 | $50 | $189 |
| Injection, diphenhydramine hcl, up to 50 mg | 119 | $1 | $3 |
| Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 99 | $23 | $84 |
| Injection, zoledronic acid, 1 mg | 97 | $7 | $69 |
| Infusion into a vein for hydration, 31-60 minutes | 82 | $25 | $156 |
| Administration of chemotherapy into vein, each additional hour | 79 | $23 | $79 |
| Administration of additional new drug or substance into vein, 1 hour or less | 79 | $52 | $178 |
| Infusion into a vein for therapy, prevention, or diagnosis, each additional hour | 77 | $15 | $56 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 64 | $25 | $89 |
| Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | 50 | $18 | $59 |
| Injection of drug or substance into vein | 47 | $30 | $156 |
| Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | 46 | $50 | $206 |
| New patient office visit, complex (60-74 min) | 32 | $153 | $581 |
| New patient office visit (45-59 min) | 28 | $132 | $446 |
| Automated urinalysis | 27 | $2 | $8 |
| Hospital follow-up visit, moderate complexity | 27 | $65 | $197 |
| Injection, methylprednisolone sodium succinate, up to 40 mg | 27 | $2 | $11 |
| Infusion, normal saline solution, sterile (500 ml = 1 unit) | 22 | $1 | $7 |
| Office visit, established patient, complex (40-54 min) | 15 | $143 | $463 |
| Initial hospital admission, high complexity | 11 | $142 | $556 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
23.1% high complexity
70.8% medium
6.1% routine
Industry Payment Transparency
Open Payments through 2024 ↗$339,421
Total received (2018-2024)
Avg $48,489/year across 7 years
Top 3% in FL for medical oncology
102
Companies
1,581
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$254,031 (74.8%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$43,554 (12.8%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$41,836 (12.3%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$9,212
2023$9,302
2022$6,213
2021$8,963
2020$51,099
2019$159,454
2018$95,177
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Lilly USA, LLC
$135,154
Novartis Pharmaceuticals Corporation
$43,370
Boehringer Ingelheim Pharmaceuticals, Inc.
$25,017
Genentech USA, Inc.
$24,164
F. Hoffmann-La Roche AG
$15,170
AstraZeneca Pharmaceuticals LP
$12,456
Seagen Inc.
$10,300
Merck Sharp & Dohme Corporation
$8,185
PFIZER INC.
$8,173
Janssen Biotech, Inc.
$8,129
Veracyte, Inc.
$5,851
Daiichi Sankyo Inc.
$4,703
NOVARTIS PHARMACEUTICALS CORPORATION
$4,105
Seattle Genetics, Inc.
$3,453
TESARO, Inc.
$2,390
Karyopharm Therapeutics Inc.
$2,287
Pharmacyclics LLC, An AbbVie Company
$2,183
E.R. Squibb & Sons, L.L.C.
$1,919
Jazz Pharmaceuticals Inc.
$1,760
Blueprint Medicines Corporation
$1,743
Foundation Medicine, Inc.
$1,595
Epizyme, Inc.,
$1,490
Celgene Corporation
$1,406
Merck Sharp & Dohme LLC
$1,104
Boehringer Ingelheim International GmbH
$1,058
GENZYME CORPORATION
$826
Incyte Corporation
$789
Amgen Inc.
$741
Gilead Sciences, Inc.
$619
Exelixis Inc.
$598
BeiGene USA, Inc.
$537
Eisai Inc.
$511
Athenex Pharmaceutical Division, LLC
$500
NanoString Technologies, Inc.
$400
Bayer HealthCare Pharmaceuticals Inc.
$335
Astellas Pharma US Inc
$315
Bayer Healthcare Pharmaceuticals Inc.
$314
GlaxoSmithKline, LLC.
$299
G1 Therapeutics, Inc.
$290
Takeda Pharmaceuticals U.S.A., Inc.
$269
Puma Biotechnology, Inc.
$258
Clovis Oncology, Inc.
$244
Ipsen Biopharmaceuticals, Inc
$235
Agios Pharmaceuticals, Inc.
$219
Mirati Therapeutics, Inc.
$214
Regeneron Healthcare Solutions, Inc.
$214
EISAI INC.
$198
ARRAY BIOPHARMA INC
$190
EMD Serono, Inc.
$167
JAZZ PHARMACEUTICALS INC.
$165
CTI BioPharma Corp.
$158
Spectrum Pharmaceuticals Inc.
$158
TerSera Therapeutics LLC
$150
Adaptive Biotechnologies Corporation
$143
Verastem, Inc.
$138
Dova Pharmaceuticals
$135
ABBVIE INC.
$119
PharmaEssentia USA Corporation
$92
Janssen Pharmaceuticals, Inc
$88
AbbVie, Inc.
$86
SOBI, INC
$85
Kyowa Kirin, Inc.
$81
SANOFI-AVENTIS U.S. LLC
$75
Pharmacyclics LLC, an AbbVie Company
$67
Kite Pharma, Inc.
$67
Taiho Oncology, Inc.
$61
Alnylam Pharmaceuticals Inc.
$60
Sumitomo Pharma America, Inc.
$60
Myriad Genetic Laboratories, Inc.
$53
Stemline Therapeutics Inc.
$52
PUMA BIOTECHNOLOGY, INC.
$48
EUSA Pharma (US) LLC
$48
Sirtex Medical Inc
$46
Epizyme, Inc.
$43
Myovant Sciences Inc.
$43
Genmab U.S., Inc.
$42
Pharmacosmos Therapeutics Inc.
$40
AMAG Pharmaceuticals, Inc.
$39
MENARINI SILICON BIOSYSTEMS, INC.
$38
ADC Therapeutics America, Inc.
$37
Rigel Pharmaceuticals, Inc.
$33
MorphoSys, US Inc.
$32
Helsinn Therapeutics (U.S.), Inc.
$32
Alexion Pharmaceuticals, Inc.
$30
GE HEALTHCARE
$30
Aurobindo Pharma USA, Inc.
$28
SERVIER PHARMACEUTICALS LLC
$28
SpringWorks Therapeutics, Inc.
$25
Legend Biotech USA Inc.
$24
AbbVie Inc.
$20
Sobi, Inc
$19
Advanced Accelerator Applications
$18
ImmunoGen, Inc.
$18
Otsuka America Pharmaceutical, Inc.
$18
Heron Therapeutics, Inc.
$17
Acrotech Biopharma Inc.
$16
Deciphera Pharmaceuticals Inc.
$14
Secura Bio, Inc.
$13
Global Blood Therapeutics, Inc.
$13
INSYS Therapeutics Inc
$11
Iovance Biotherapeutics, Inc.
$9
Janssen Scientific Affairs, LLC
$8
Top 3 companies account for 60.0% of total payments
Associated products mentioned in payments ›
ADCETRIS · AFINITOR · AKYNZEO · ALIMTA · AYVAKIT · Abraxane · Alecensa · Aliqopa · Amtagvi · Avastin · BAVENCIO · BELEODAQ · BESREMI · BLENREP · BOSULIF · BRAFTOVI · BRUKINSA · BYL719 · Bavencio · Blincyto · CABOMETYX · CALQUENCE · CERDELGA · CEREZYME · CINVANTI · COSELA · CYRAMZA · Cabometyx · Cellsearch · Copiktra · Creon · DARZALEX · DOPTELET · Doptelet · ELAHERE · ELIQUIS · ELITEK · ELREXFIO · EMPLICITI · ENHERTU · ERLEADA · Elahere · Enhertu · Epkinly · FERAHEME · FOUNDATIONACT · FOUNDATIONONE · Fabhalta · Farydak · Folotyn · GAUCHER-DISEASE · GAVRETO · GAZYVA · GILOTRIF · GIVLAARI · HYQVIA · Halaven · Herceptin · IBRANCE · IDHIFA · IMBRUVICA · IMFINZI · INFLECTRA · INJECTAFER · INLYTA · INREBIC · Imbruvica · Inrebic · JADENU · JAKAFI · JAYPIRCA · JEMPERLI · JEVTANA · Jivi · KANJINTI · KEYTRUDA · KISQALI · KRAZATI · Kadcyla · Kyprolis · LENVIMA · LIBTAYO · LORBRENA · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · Lonsurf · Lutathera · MEKINIST · MONJUVI · MVASI · MYLOTARG · MYRISK · Marqibo · NERLYNX · NINLARO · Nerlynx · Neulasta · Nexavar · Nplate · Nubeqa · OCREVUS · OGSIVEO · OJJAARA · ONPATTRO · ONUREG · OPDIVO · OPDUALAG · ORGOVYX · OXBRYTA · Onivyde · Oral Paclitaxel · Orserdu · PADCEV · PEMAZYRE · PIQRAY · PLUVICTO · POTELIGEO · PRECISETUMOR · PROMACTA · PROSIGNA ASSAY · Padcev · Perjeta · Polivy · Pomalyst · Poteligeo · Prolia · QINLOCK · REBLOZYL · RETACRIT · RETEVMO · ROLVEDON · RYBREVANT · RYDAPT · Revlimid · Rezlidhia · Rituxan · Rubraca · SANDOSTATIN · SANDOSTATIN LAR · SARCLISA · SCEMBLIX · SHINGRIX · SIR-Spheres Microspheres · SOMATULINE DEPOT · SPRYCEL · SUTENT · SYNDROS · Somatuline Depot · Stivarga · Sylvant · TAFINLAR · TAGRISSO · TASIGNA · TAZVERIK · TECENTRIQ · TECVAYLI · TEVIMBRA · TIBSOVO · TIVDAK · TUKYSA · Tazverik · Tecentriq · Tibsovo · Trodelvy · ULTOMIRIS · VARUBI · VENCLEXTA · VERZENIO · VONJO · VONVENDI · VOTRIENT · VYXEOS · Venclexta · Vitrakvi · Vonjo · Vyloy · XALKORI · XARELTO · XGEVA · XOSPATA · XPOVIO · XTANDI · Xospata · Xtandi · Yescarta · ZEJULA · ZEPZELCA · ZOLADEX · ZYKADIA · Zoladex · clonoSEQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (75%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in medical oncology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 3% for medical oncology in FL.
Equivalent to $461 per 100 Medicare services performed
Geographic Context
Medical Oncologys within 10 mi
11
Per 100K population
1.4
County median income
$73,099
Nearest hospital
LEE MEMORIAL HOSPITAL
8.0 mi
8.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Hart is a mixed practice specialist, with above-average Medicare volume (top 30% in FL), and high industry engagement (speaking/promotional, top 3%), with 20 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Hart experienced with iron infusion (feraheme)?
Based on Medicare claims data, Dr. Hart performed 16,320 iron infusion (feraheme) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Hart receive payments from pharmaceutical companies?
Yes. Dr. Hart received a total of $339,421 from 102 companies across 1,581 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Hart's costs compare to other medical oncologys in Fort Myers?
Dr. Hart's average Medicare payment per service is $13. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Hart) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Medical Oncologys in Fort Myers
Browse medical oncologys in Fort Myers ranked by procedure volume and transparency data.
Highest volume
Top Medical Oncologys in FL
Medical Oncologys ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Medical Oncologys in FL
Which FL medical oncologys receive the most from drug and device companies.
By company
Lilly USA, LLC Payments to Doctors
See all physicians who received payments from Lilly USA, LLC.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
Boehringer Ingelheim Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Boehringer Ingelheim Pharmaceuticals, Inc..
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology